2022 annual financial data
BioNexus Gene Lab 2022 Net margin
Direct answer
Net margin was -3.26%.
Operating income was -291,177 USD and net income was -355,966 USD.
Operating cash flow was 544,028 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,928,707 USD
- Operating income
- -291,177 USD
- Net income
- -355,966 USD
- Operating cash flow
- 544,028 USD